References
- Stout AP, Cooley SGE. Carcinoma of sweat glands. Cancer. 1951;4(3):521–536.
- Aldrees SS, Zoroquiain P, Alghamdi SA, Logan P, Kavalec C, Burnier M. Apocrine adenocarcinoma of the eyelid. Int J Ophthalmol. 2016;9(7):1086–1088.
- Baker MS, Yin VT, Ivan D, et al. Epidemiology and prognosis of primary periocular sweat gland carcinomas. Ophthal Plast Reconstr Surg. 2017;33(2):101–105.
- Hollowell KL, Agle SC, Zervos EE, Fitzgerald TL. Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm. J Surg Oncol. 2012;105(4):415–419.
- Figueira EC, Danks J, Watanabe A, Khong JJ, Ong L, Selva D. Apocrine adenocarcinoma of the eyelid: case series and review. Ophthal Plast Reconstr Surg. 2013;29(6):417–423.
- Valenzuela AA, Cupp DG, Heathcote JG. Primary apocrine adenocarcinoma of the eyelid. Orbit. 2012;31(5):316–318.
- Ni C, Wagoner M, Kieval S, Albert DM. Tumours of the Moll’s glands. Br J Ophthalmol. 1984;68(7):502–506.
- Kipkie GF, Haust MD. Carcinoma of apocrine glands; report of case. AMA Arch Derm. 1958;78(4):440–445.
- Ansai S, Koseki S, Hozumi Y, Kondo S. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation. Am J Dermatopathol. 1995;17(3):249–255.
- Fuertes L, Santonja C, Kutzner H, Requena L. Inmunohistoquímica en dermatopatología: revisión de los anticuerpos utilizados con mayor frecuencia (parte i). Actas Dermosifiliogr. 2013;104(2):99–127.